Philip Vlummens

Journal Article
A1
open access

Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging

Thomas Van Den Berghe (UGent) , Bert Verberckmoes, Nicolas Kint (UGent) , Steven Wallaert (UGent) , Nicolas De Vos, Chloé Algoet (UGent) , Maxim Behaeghe, Julie Dutoit (UGent) , Nadine Van Roy (UGent) , Philip Vlummens (UGent) , et al.

(2024) INSIGHTS INTO IMAGING. 15(1).

Add to list

Journal Article
A1
open access

Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells

Dorien Clarisse (UGent) , Stefan Prekovic, Philip Vlummens (UGent) , Eleni Staessens (UGent) , Karlien Van Wesemael (UGent) , Jonathan Thommis (UGent) , Daria Fijalkowska (UGent) , Guillaume Acke (UGent) , Wilbert Zwart, Ilse M. Beck, et al.

(2023) CELLULAR AND MOLECULAR LIFE SCIENCES. 80(9).

Add to list

Journal Article
A1
open access

Inhibition of the protein arginine methyltransferase PRMT5 in high-risk multiple myeloma as a novel treatment approach

Philip Vlummens (UGent) , Stefaan Verhulst, Kim De Veirman, Anke Maes, Eline Menu, Jerome Moreaux, Hugues De Boussac, Nicolas Robert, Elke De Bruyne, Dirk Hose, et al.

(2022) FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. 10.

Add to list

Journal Article
A1
open access

System Xc(-) inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance

Fang Wang, Inge Oudaert, Chenggong Tu, Anke Maes, Arne Van Der Vreken, Philip Vlummens (UGent) , Elke De Bruyne, Kim De Veirman, Yanmeng Wang, Rong Fan, et al.

(2022) CANCER LETTERS. 535.

Add to list

Identifying patients with chronic lymphocytic leukemia without need of treatment : end of endless watch and wait?

Christian Brieghel, Veerle Galle (UGent) , Rudi Agius, Caspar Da Cunha-Bang, Michael A. Andersen, Philip Vlummens (UGent) , Mattias Mattsson, Richard Rosenquist, Karin E. Smedby, Carmen D. Herling, et al.

(2022) EUROPEAN JOURNAL OF HAEMATOLOGY. 108(5). p.369-378

Add to list

Journal Article
A1
open access

Pyrroline-5-carboxylate reductase 1 : a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis

Inge Oudaert, Hatice Satilmis, Philip Vlummens (UGent) , Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquiere, Karin Vanderkerken, Kim De Veirman, et al.

(2022) JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 41(1).

Add to list

A mini-review on aplastic anemia, illustrated by a case report on bone marrow hot pockets mimicking sclerotic bone metastases

Emilie Janssens, Jo Van Dorpe (UGent) , VANESSA VAN HENDE (UGent) , Ine Moors (UGent) , Philip Vlummens (UGent) and Ciel De Vriendt (UGent)

(2022) ACTA CLINICA BELGICA. 77(2). p.410-415

Add to list

Journal Article
A1
open access

CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma

Kim De Veirman, Janik Puttemans, Ahmet Krasniqi, Thomas Ertveldt, Heleen Hanssens, Ema Romao, Dirk Hose, Cleo Goyvaert, Philip Vlummens (UGent) , Serge Muyldermans, et al.

(2021) ONCOIMMUNOLOGY. 10(1).

Add to list

Journal Article
A1
open access

Quality of life analyses in patients with multiple myeloma : results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

Gabriel Tremblay, Patrick Daniele, Janis Breeze, Lingling Li, Jatin Shah, Sharon Shacham, Michael Kauffman, Monika Engelhardt, Ajaj Chari, Ajay Nooka, et al.

(2021) BMC CANCER. 21(1).

Add to list

Compass : a prospective study comparing clinical evaluation with different geriatric screening methods in newly diagnosed elderly multiple myeloma patients

Michel Delforge, Jolien Raddoux, Cindy Kenis, Anneleen Vanhellemont, Philippe Mineur, Ellen Hoornaert, Ka Lung Wu, Jo Caers, Koen Van Eygen, Alain Kentos, et al.

(2021) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. In Clinical Lymphoma Myeloma & Leukemia 21(Supplement 2). p.S124-S124

Academic Bibliography

Philip Vlummens

Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging

Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells

Inhibition of the protein arginine methyltransferase PRMT5 in high-risk multiple myeloma as a novel treatment approach

System Xc(-) inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance

Identifying patients with chronic lymphocytic leukemia without need of treatment : end of endless watch and wait?

Pyrroline-5-carboxylate reductase 1 : a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis

A mini-review on aplastic anemia, illustrated by a case report on bone marrow hot pockets mimicking sclerotic bone metastases

CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma

Quality of life analyses in patients with multiple myeloma : results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

Compass : a prospective study comparing clinical evaluation with different geriatric screening methods in newly diagnosed elderly multiple myeloma patients

Contents

Support

Contact